CN
83-31-8
应用筛选条件
关键词:'83-31-8'
显示 1-30 共 430 条结果 关于 "83-31-8" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
18 6 7 0 104 103 27 52 41 97 99 82 94 62 114 50 107 113
101 91 98 104 87 65 36 31 89 88 62 86 61 97 77 108 100 95 83 87 88
SMC®Plate Washer Evaluation Kit
59 64 61 60 81 64 7 11
F 76 63 73 83 73 70 83 65 70 84 66 87 74 8 11
G 78 62 55 44 68 51 56 54 55 68 62 83 61
Data Sheet - SAB4200870
Proc Natl Acad Sci USA.,
106: 2365-70 (2009).
7. Santacruz A., et al., Br J Nutr., 104:
83–92 (2010).
8. Wang L., et al., Appl Environ Microbiol., 77:
6718-21 (2011).
Notice
We provide information
Product Information Sheet - T3766
Potential anticancer agents.
LXI. A novel synthesis of "spongo" nucleosides.
J. Am. Chem. Soc., 83, 2208 (1961).
2. Rubsam, L. Z., et al., Superior cytotoxicity with
ganciclovir compared with
The Effective Use of Protein Kinase Inhibitors
18 6 7 0 104 103 27 52 41 97 99 82 94 62 114 50 107 113
101 91 98 104 87 65 36 31 89 88 62 86 61 97 77 108 100 95 83 87 88
Non-Human Primate Cytokine/Chemokine/Growth Factor Panel A Magnetic Bead Panel
IFNα2 84 83
IL-10 91 94
IL-2 83 86
IL-15 84 84
IL-17A 85 86
IL-6 83 86
Granzyme B 88 85
IL-8 85 83
IL-1Ra 86 90
IL-1β 80 87
IL-23 93 84
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
77 91 109
1:8 dil 123 84 48 108 98 91 94 63 87 105 70 110 66 84 111
1:16 dil 129 84 42 108 87 90 94 61 83 100 64 114 61 75 116
Protocol- PRCYTA-40K|PRCYTA-40K-PX38|PRCYTA-40K-BK38|PRCYTA-40K-PX48|PRCYTA-40K-BK48
1α 86 89
Granzyme A 85 85
IFNα2 84 83
IL-10 91 94
IL-2 83 86
IL-15 84 84
IL-17A 85 86
IL-6 83 86
MMP Activation Chart
/21712
activeMMP-7 1:1 37oC, 4h 83 & 80 78 74.6* L
16RTNL; C-term
cleavage
0.25x Imai, jbc270/1995/6691
APMA, 1mM +
activeMMP-7 (1:1)
37oC, 12h 83 62 66.6* M
75RTPR & F88QTFE; C-
Panorama Ab Microarray - Gene Regulation I List of Antibodies
hABH3 clone: hABH3-99 A8353
29 MeCP2 M9317
30 MeCP2
Data Sheet - G1160 - Lot 087H4806
Smith, D., and Johnson, K., Gene, 67, 31 (1988).
3. Smith, D., et al., Proc. Natl. Acad. Sci. USA, 83,
8703 (1986).
4. Cartwright, G., et al., J. Immunol. Meth., 179, 31
(1995).
5. Hibma, M., et al.
Data Sheet - T9573
dibutyrate in the
presence of calcium increased the phosphorylation of
only serine 40. Serine 31 and serine 8 were not
phosphorylated. The Ca2+-stimulated phosphorylation
of serine 40 was reduced by specific
Data Sheet - M3528
Ther. 262, 25-31 (1992).
2. Thompson, P.I. et al. "Morphine-6β-glucuronide: A metabolite of morphine with greater emetic potency than
morphine in the ferret." Br. J. Pharmacol. 106, 3-8 (1992).
3. Gong
Product Information Sheet - P4633
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Data Sheet - SAB4200055
References
1. Smith, D.B., et al., Proc. Natl. Acad. Sci. USA, 83,
8703-8707 (1986).
2. Smith, D.B., and Johnson, K.S., Gene, 67, 31-40
(1988).
GG,TD,KAA,PHC 01/10-1
Sigma brand products
Data Sheet - SAB4200237
References
1. Smith, D.B., et al., Proc. Natl. Acad. Sci. USA, 83,
8703-8707 (1986).
2. Smith, D.B., and Johnson, K.S., Gene, 67, 31-40
(1988).
DS,PHC 06/17-1
Quality Control Ranges: Milliplex® MAP Equine Cytokine/Chemokine Magnetic Bead Panel
Control 2 1649 – 3426 pg/mL Control 2 14882 – 30909 pg/mL
GM-CSF Control 1 31 – 65 pg/mL IL-8 Control 1 381 – 791 pg/mL
Data Sheet - R1030
optimal working dilutions by titration.
References
1. Bos, J.L., et al., Biochem. Soc. Trans., 31, 83-86
(2003).
2. Stork, P.J.S., and Dillon, T.J., Blood, 106, 2952-
2961 (2005).
3. Fukuhra
Product Information Sheet - A5486
endothelial growth factor receptor-2) prior to rat
colon tumour development. Clin. Sci. (Lond)., 106,
83-91 (2004).
2. Marotta, F. et al., Chemopreventive effect of a
probiotic preparation on the development
Product Information - P5530
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Product Information - P4758
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Data Sheet - P1431
Biophys. Acta, 845(3),
533-539 (1985).
8. Sacks, D. et al., Biochem. J., 286(Pt 1), 211-216
(1992).
9. Fukami, Y. et al., Proc. Natl. Acad. Sci. USA,
83(12), 4190-4193 (1986).
10. Colca, J.
Data Sheet - SAB4200680
1989).
8. Dakshinamurti K., et al., Biochem. J.,237, 477-
82 (1986).
9. Burns J., et al., J. Clin.Pathol., 40, 858-64
(1987).
10. Okabe S. and Hirokawa N., PNAS (USA), 86,
4127-31 (1989).
Novabiochem Innovations 03/10
Subirós-Funosas, et al. (2010) Org. Biomol. Chem., 8, 3665.
6. J. Coste, et al. (1990) Tetrahedron Lett., 31, 205.
7. R. Behrendt, et al., Poster 83, Presented at the 31st European peptide Symposium
Impurities & Related Compounds: Reference Materials
144701-48-4
206184-49-8
202138-50-9
58-22-0
57-85-2
522-48-5
13472-36-1
83-67-0
411207-31-3
2398-96-1
124937-52-6
97240-79-4
73-67-6
1197-18-8
501-36-0
157283-
CHEMISCREENTM MEMBRANE PREPARATION RECOMBINANT HUMAN 2 ADRENORECEPTOR RECEPTOR
5476) • F: 1-800-437-7502
www.millipore.com
HTS073M/31-JAN-2013/DJ/Formatting
-13 -12 -11
Data Sheet - SAB4200719
).
8. Zidane N., et al., Biosci Rep., 33, 113-24 (2012).
9. Iorio V., et al., Adv Wound Care (New Rochelle),
4, 250-63 (2015).
10. Halper J. and Kjaer M., Adv Exp Med Biol.
Periodensystem der Elemente / Periodic table of Elements
86 *222.02 –71
–61.7
Rn
2
[Xe] 4f145d106s26p6
102.91 31
45
2
1966 4
3727 5
1.5 6
[Kr] 4d85s1 8
0, 1, 2, 3
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
82
83 84,85
86
3.0 4.0 5.0 6.0 7.02.0 Min
1
2 3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18,19
Periodic Table of the Elements - Certipur ICP / AAS standards
Rn
2
[Xe] 4f145d106s26p6
114
FI
116
Lv
102.91 31
45
2
1966 4
3727 5
1.5 6
[Kr]
1/15